TY  - JOUR 
AU  - Vidriales Vicente, María Belén
AU  - Pérez, José J
AU  - López-Berges, Maria Consuelo
AU  - Gutiérrez Gutiérrez, Norma Carmen
AU  - Ciudad, Juana
AU  - Lucio, Paulo
AU  - Vázquez López, María Lourdes
AU  - García Sanz, Ramón
AU  - Cañizo Fernández-Roldán, María Consuelo del
AU  - Fernández‐Calvo, Javier
AU  - Ramos, Fernando
AU  - Rodríguez, M. Jesus
AU  - Calmuntia, M José
AU  - Porwith, Ana
AU  - Orfao de Matos Correia e Vale, José Alberto
AU  - San Miguel Izquierdo, Jesús Fernando
PY  - 2003
SN  - 0006-4971
UR  - http://hdl.handle.net/10366/155249
AB  - [EN]Investigation of minimal residual disease (MRD) in acute leukemias by immunophenotyping and/or molecular techniques is proving to be increasingly valuable for disease monitoring. In acute lymphoblastic leukemia (ALL), most MRD studies have focused...
LA  - eng
PB  - American Society of Hematology
KW  - Lympholastic leukemia
KW  - Flow Cytometry
KW  - Monitorization
KW  - Minimal residual disease
KW  - Disease-Free Survival
KW  - Immunophenotyping
KW  - Aged
KW  - Bone Marrow
KW  - Analysis of Variance
KW  - Adult
KW  - Flow Cytometry
KW  - Humans
KW  - Adolescent
KW  - Middle Aged
KW  - Prognosis
KW  - Recurrence
KW  - Time Factors
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Remission Induction
TI  - Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value
DO  - 10.1182/blood-2002-08-2613
T2  - Blood
VL  - 101
M2  - 4695
ER  -